Carmel Pharma Overview

  • Founded
  • 1994


  • Status
  • Acquired/​Merged

  • Employees
  • 2


  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $287M

Carmel Pharma General Information


Developer of a closed system drug transfer device. The company provides clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. Their PhaSeal system is a closed system for handling antibiotics and cytostatic drugs which minimizes the leakage and spread of aerosols into the work environment, allowing more efficient handling near the patient.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Primary Office
  • Aminogatan 30
  • SE-402 28 Molndal
  • Sweden
+46 031-703 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carmel Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 16-Aug-2011 $287M 00000 Completed Product Development
4. Secondary Transaction - Private 11-May-2009 Completed
3. Secondary Transaction - Private 14-Dec-2005 Completed
2. Early Stage VC 01-Jan-1999 Completed Product Development
1. Early Stage VC 01-Jan-1997 Completed Product Development
To view Carmel Pharma’s complete valuation and funding history, request access »

Carmel Pharma Patents

Carmel Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2018122165-A Deployment in medical connector device Active 16-May-2018 00
JP-2017145059-A Non-removable tamper resistant lid Active 23-May-2017
JP-2017070772-A Connection device for medical treatment Active 28-Nov-2016 0
JP-2016040180-A Non-removable tamper resistant lid Active 08-Oct-2015
JP-2014128682-A Connection device and method for connecting medical device to connection device Active 16-Jan-2014
To view Carmel Pharma’s complete patent history, request access »

Carmel Pharma Executive Team (5)

Name Title Board Seat Contact Info
Lennart Bergström Chief Financial Officer
Lars Svenstig Chief Information Officer
Goran Wessman Founder
Dan Pitulia Chief Executive Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Carmel Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Carmel Pharma Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3i Group PE/Buyout Minority 000 0000 000000 0
Industrifonden Venture Capital Minority 000 0000 000000 0
Patricia Industries PE/Buyout Minority 000 0000 000000 0
Priveq Investment PE/Buyout Minority 000 0000 000000 0
Scandinavian Life Science Venture Venture Capital Minority 000 0000 000000 0
To view Carmel Pharma’s complete investors history, request access »